首页 > 市场调查报告书 > 製药

动物用医药

市场调查报告书

商品编码

1489250

全球伴侣动物药品市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Companion Animal Pharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球伴侣动物药品市场需求预计将从 2023 年的 206.9 亿美元达到 2032 年近 322.6 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 5.06%。

伴侣动物药品是专门为狗、猫和其他家畜等宠物开发的药物和治疗方法。这些药物可解决各种健康问题，包括感染、慢性病、疼痛管理和预防保健。产品可包括抗生素、疫苗、抗发炎药物以及关节炎、心丝虫和跳蚤感染的治疗药物。这些药物的开发和监管确保它们对动物应用安全有效，有助于维持宠物的健康和福祉，宠物通常被认为是家庭的重要成员。

市场动态

由于全球宠物饲养量的增加以及人类与动物之间联繫的日益加深，伴侣动物药品市场正在经历成长。随着越来越多的人将宠物视为家庭成员，他们更愿意为宠物的健康和福祉花钱。关节炎、糖尿病和心血管疾病等伴侣动物慢性疾病的增加增加了对有效药物治疗的需求。此外，兽医学的进步导致了针对伴侣动物的新的和改进的药物的开发，提高了它们的生活品质和寿命。宠物主人对预防性医疗措施和先进治疗方案的认识不断增强，这进一步推动了市场的发展。

此外，兽医诊所和医院的扩张以及兽医专业人员数量的增加支持了伴侣动物药品的成长。对动物保健产品的监管批准和支持也在推动市场成长方面发挥着不可或缺的作用。此外，宠物保险的采用使得宠物主人能够负担昂贵的治疗费用，从而增加了对伴侣动物药品的需求。然而，高昂的开发成本和严格的监管要求可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球伴侣动物药品市场的每个细分市场进行了包容性评估。伴侣动物製药产业的成长和趋势为本研究提供了整体方法。

市场区隔

伴侣动物药品市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按形式

马匹
猫
小狗
伴侣动物

按指示

皮肤科疾病
传染性疾病
行为疾病
骨科疾病

按配销通路

医院药房
电子商务
零售

按产品分类

疫苗
生物製剂

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲伴侣动物药品市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。伴侣动物药品市场的主要参与者包括默克动物保健公司、硕腾公司、Dechra Pharmaceuticals PLC、Elanco动物保健公司、Neogen Corporation、勃林格殷格翰动物保健公司、Aratana Therapeutics、拜耳动物保健公司、Norbrook Laboratories、 Virbac、Kindred Biosciences、Ceva圣动物。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按形式分類的市场吸引力分析
- 按指标进行的市场吸引力分析
- 按配销通路分類的市场吸引力分析
- 按产品分類的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球伴侣动物药品市场分析：依形式

表格概览
历史和预测资料分析形式
马匹
猫
小狗
伴侣动物

第 6 章：全球伴侣动物药品市场分析：依适应症分类

按指示概述
按指示进行历史和预测资料分析
皮肤科疾病
传染性疾病
行为疾病
骨科疾病

第 7 章：全球伴侣动物药品市场分析：按分销管道

配销通路概述
按配销通路进行历史和预测资料分析
医院药房
电子商务
零售

第 8 章：全球伴侣动物药品市场分析：副产品

概述（按产品）
按产品分类的历史和预测资料分析
疫苗
生物製剂

第 9 章：全球伴侣动物药品市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：伴侣动物製药公司的竞争格局

伴侣动物药品市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
Merck Animal Health

公司简介
公司收入
产品
最近的发展

Zoetis Inc.

公司简介
公司收入
产品
最近的发展

Dechra Pharmaceuticals PLC

公司简介
公司收入
产品
最近的发展

Elanco Animal Health

公司简介
公司收入
产品
最近的发展

Neogen Corporation

公司简介
公司收入
产品
最近的发展

Boehringer Ingelheim Animal Health

公司简介
公司收入
产品
最近的发展

Aratana Therapeutics

公司简介
公司收入
产品
最近的发展

Bayer Animal Health

公司简介
公司收入
产品
最近的发展

Norbrook Laboratories

公司简介
公司收入
产品
最近的发展

Virbac

公司简介
公司收入
产品
最近的发展

Kindred Biosciences

公司简介
公司收入
产品
最近的发展

Ceva Sante Animale

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114742

The global demand for Companion Animal Pharmaceuticals Market is presumed to reach the market size of nearly USD 32.26 Billion by 2032 from USD 20.69 Billion in 2023 with a CAGR of 5.06% under the study period 2024-2032.

Companion animal pharmaceuticals are medications and treatments specifically developed for pets like dogs, cats, and other domestic animals. These pharmaceuticals address various health issues, including infections, chronic conditions, pain management, and preventive care. Products can include antibiotics, vaccines, anti-inflammatory drugs, and treatments for arthritis, heartworm, and flea infestations. The development and regulation of these medications ensure they are safe and effective for animal application, contributing to maintaining the health and well-being of pets, which are often considered important members of their families.

MARKET DYNAMICS

The companion animal pharmaceuticals market is experiencing growth due to the increasing pet ownership worldwide, coupled with a growing human-animal bond. As more people consider pets family members, they are more willing to spend on their health and well-being. The rise in chronic diseases among companion animals, such as arthritis, diabetes, and cardiovascular conditions, has increased the demand for effective pharmaceutical treatments. Additionally, advancements in veterinary medicine have resulted in the development of new and improved pharmaceuticals for companion animals, enhancing their quality of life and longevity. The growing awareness among pet owners about preventive healthcare measures and the availability of advanced treatment options is further boosting the market.

Furthermore, the expansion of veterinary clinics and hospitals and the increasing number of veterinary professionals support the growth of companion animal pharmaceuticals. Regulatory approvals and support for animal healthcare products also play an integral role in driving market growth. Moreover, pet insurance adoption has made expensive treatments more affordable for pet owners, increasing the demand for companion animal pharmaceuticals. However, high development costs and stringent regulatory requirements may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Companion Animal Pharmaceuticals. The growth and trends of Companion Animal Pharmaceuticals industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Companion Animal Pharmaceuticals market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Form

Horses
Cats
Dogs
Companion Animals

By Indication

Dermatologic Diseases
Infectious Diseases
Behavioral Diseases
Orthopedic Diseases

By Distribution Channel

Hospital Pharmacy
E-Commerce
Retail

By Product

Vaccine
Biologics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Companion Animal Pharmaceuticals market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Companion Animal Pharmaceuticals market include Merck Animal Health, Zoetis Inc., Dechra Pharmaceuticals PLC, Elanco Animal Health, Neogen Corporation, Boehringer Ingelheim Animal Health, Aratana Therapeutics, Bayer Animal Health, Norbrook Laboratories, Virbac, Kindred Biosciences, Ceva Sante Animale. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. COMPANION ANIMAL PHARMACEUTICALS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Form
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Product
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY FORM

5.1. Overview By Form
5.2. Historical and Forecast Data Analysis By Form
5.3. Horses Historic and Forecast Sales By Regions
5.4. Cats Historic and Forecast Sales By Regions
5.5. Dogs Historic and Forecast Sales By Regions
5.6. Companion Animals Historic and Forecast Sales By Regions

6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY INDICATION

6.1. Overview By Indication
6.2. Historical and Forecast Data Analysis By Indication
6.3. Dermatologic Diseases Historic and Forecast Sales By Regions
6.4. Infectious Diseases Historic and Forecast Sales By Regions
6.5. Behavioral Diseases Historic and Forecast Sales By Regions
6.6. Orthopedic Diseases Historic and Forecast Sales By Regions

7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data Analysis By Distribution Channel
7.3. Hospital Pharmacy Historic and Forecast Sales By Regions
7.4. E-Commerce Historic and Forecast Sales By Regions
7.5. Retail Historic and Forecast Sales By Regions

8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY PRODUCT

8.1. Overview By Product
8.2. Historical and Forecast Data Analysis By Product
8.3. Vaccine Historic and Forecast Sales By Regions
8.4. Biologics Historic and Forecast Sales By Regions

9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE COMPANION ANIMAL PHARMACEUTICALS COMPANIES

10.1. Companion Animal Pharmaceuticals Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF COMPANION ANIMAL PHARMACEUTICALS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Merck Animal Health
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Zoetis Inc.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Dechra Pharmaceuticals PLC
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Elanco Animal Health
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Neogen Corporation
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Boehringer Ingelheim Animal Health
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Aratana Therapeutics
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Bayer Animal Health
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Norbrook Laboratories
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Virbac
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Kindred Biosciences
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Ceva Sante Animale
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments